ESMO 2024 Summary: Bladder Cancer Highlights - JCOG1019, TOMBOLA, and SunRISe-4

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Summary: Bladder Cancer Highlights - JCOG1019, TOMBOLA, and SunRISe-4

By 2024 ESMO Annual Meeting Insights Hub FEATURING Bogdana Schmidt

115 views

September 23, 2024

Comments 0

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh

2024 ESMO Annual Meeting Insights Hub: GU Videos

New

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

251 views

3 weeks ago

ESMO 2024 Summary: Practice-Changing Trials for Patients With Locali…

2024 ESMO Annual Meeting Insights Hub

P. Grivas

245 views

2 months ago

ESMO 2024 Summary: Important GU Trials - EV-103 5-Year Follow-Up (la…

2024 ESMO Annual Meeting Insights Hub

E. Plimack

173 views

1 month ago

View All

BLADDR 2024 - Hybrid Global Forum on GU Oncology

Wed, Nov 27, 2024

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

1.4K views

5 months ago

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

1.5K views

8 months ago

Bladder Cancer Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

1.4K views

5 months ago

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views

7 months ago

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

7 months ago

Updates in the Treatment and Management of Bladder Cancer

Integrity CE

M. Galsky, B. Guercio

283 views

3 months ago

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Total Health

M. Reimers

529 views

8 months ago

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

276 views

1 month ago

ESMO 2024 Summary: Practice-Changing Trials for Patients With Locali…

2024 ESMO Annual Meeting Insights Hub

P. Grivas

245 views

2 months ago

Bladder Cancer Highlights From ESMO 2023: Comparing and Contrasting …

Insights from 2023 ESMO Annual Meeting

G. Sonpavde

853 views

1 year ago

ESMO 2024 Summary: Important GU Trials - EV-103 5-Year Follow-Up (la…

2024 ESMO Annual Meeting Insights Hub

E. Plimack

173 views

1 month ago

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

533 views

4 months ago

New

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

251 views

3 weeks ago

NCCN Guidelines Updates for the Treatment of Metastatic Urothelial C…

University of Colorado Cancer Center

T. Flaig

337 views

6 months ago

Urothelial Carcinoma: New Developments

Weill Cornell Medicine Oncology & Hematology

C. Sternberg

344 views

5 months ago

ASCO® 2024 Summary: "Bladder and RCC Highlights"

2024 ASCO® Annual Meeting Insights Hub

K. Tawagi, N. Reizine

263 views

4 months ago

Current Updates in Urothelial Cancer: Clinical Implications for Prac…

Kriti Mittal

402 views

8 months ago

ASCO® GU 2024 Summary: "Key Highlights in Bladder/Urothelial Carcino…

Insights from 2024 ASCO® GU Annual Meeting

G. Sonpavde

415 views

9 months ago

Trastuzumab Deruxtecan Approval for Metastatic HER2+ Bladder Cancer

UCSF School of Medicine

V. Koshkin

262 views

5 months ago

Sequencing 1L Therapies in Metastatic Urothelial Carcinoma

Scripps Health

P. Grivas

319 views

8 months ago

AUTOPLAY

Login

Login

Join VuMedi

ESMO 2024 Summary: Bladder Cancer Highlights - JCOG1019, TOMBOLA, and SunRISe-4

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

2024 ESMO Annual Meeting Insights Hub: GU Videos

ESMO 2024 Summary: Developmental Therapeutics Highlights

ESMO 2024 Summary: Practice-Changing Trials for Patients With Locali…

ESMO 2024 Summary: Important GU Trials - EV-103 5-Year Follow-Up (la…

Recommended

BLADDR 2024 - Hybrid Global Forum on GU Oncology

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

Recent GU Developments and Their Clinical Implications

Bladder Cancer Highlights From ASCO® 2024

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Hyperprogression in Cancer Treated With Immunotherapy

Updates in the Treatment and Management of Bladder Cancer

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

ESMO 2024 Summary: Practice-Changing Trials for Patients With Locali…

Bladder Cancer Highlights From ESMO 2023: Comparing and Contrasting …

ESMO 2024 Summary: Important GU Trials - EV-103 5-Year Follow-Up (la…

Developmental Therapeutics Highlights From ASCO® 2024

ESMO 2024 Summary: Developmental Therapeutics Highlights

NCCN Guidelines Updates for the Treatment of Metastatic Urothelial C…

Urothelial Carcinoma: New Developments

ASCO® 2024 Summary: "Bladder and RCC Highlights"

Current Updates in Urothelial Cancer: Clinical Implications for Prac…

ASCO® GU 2024 Summary: "Key Highlights in Bladder/Urothelial Carcino…

Trastuzumab Deruxtecan Approval for Metastatic HER2+ Bladder Cancer

Sequencing 1L Therapies in Metastatic Urothelial Carcinoma